Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Merck And Co Inc (MRK)

2015-01-25@12:30:09 ET
Glaucoma Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at RnRMarketResearch.com (PRW)

2015-01-23@22:13:18 ET
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany (MTO)

2015-01-23@20:45:28 ET
Dengue Therapeutic Pipeline Drugs and Companies Review H1 2015 Report at RnRMarketResearch.com (PRW)

2015-01-23@11:39:47 ET
Top 3 Companies in the Pharmaceuticals Industry With the Highest Dividend Yield (CBRX, PFE, MRK) (F70)

2015-01-23@10:08:12 ET
Merck (MRK) Showing Bullish Technicals With Resistance At $63.46 (FBM)

2015-01-23@07:29:01 ET
Research and Markets: Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany (BIZ)

2015-01-23@05:27:55 ET
Form 144: Filing to Sell 74200 Shares of Merck & Co Inc (MRK) (VKR)

2015-01-22@15:34:13 ET
Merck (MRK) Showing Bullish Technicals With Support At $61.64 (FBM)

2015-01-22@15:29:12 ET
Merck, on Behalf of its Wholly Owned Subsidiary, Cubist Pharmaceuticals, Announces Tender Offer for Cubist's 2.50% Convertible Senior Notes Due 2017, 1.125% Convertible Senior Notes due 2018 and 1.875% Convertible Senior Notes due 2020 (BIZ)

2015-01-22@10:35:50 ET
Merck (MRK) Approaches New Downside Target of $61.64 (F79)

2015-01-22@09:58:59 ET
Watch for Shares of Merck (MRK) to Approach Support at $61.64 (PSM)

2015-01-22@08:01:13 ET
Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors (BIZ)

2015-01-22@06:34:16 ET
Merck concludes tender offer to acquire Cubist at USD102.00 per share (MTO)

2015-01-22@06:30:30 ET
Global Ankylosing Spondylitis Market 2015-2019 (MTO)

2015-01-21@18:42:40 ET
Deal snapshot: MERCK CLOSES TENDER OFFER FOR USD 8.4BN CUBIST ACQUISITION (MTN)

2015-01-21@18:19:20 ET
M and A Navigator: Deal pipeline - 21 January (MTN)

2015-01-21@17:25:46 ET
Merck Closes Tender Offer for USD 8.4bn Cubist Acquisition (MTN)

2015-01-21@15:53:06 ET
Merck (MRK) Showing Bullish Technicals With Resistance At $64.02 (FBM)

2015-01-21@08:00:37 ET
Merck Completes Tender Offer to Acquire Cubist (BIZ)

2015-01-21@01:06:50 ET
Raytheon Sarcos Acquired by Management-Led Consortium (MTN)